None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Age 18-55 years • Good sleep quality (Pittsburg Sleep Quality Index
Exclusion criteria
Exclusion criteria: • Inability to follow procedures (eg due to insufficient knowledge of project language, cognitive or auditory impairments, etc.) • Individuals with known structural brain injury • Individuals with a history of epileptic seizures or suspected epilepsy • History or presence of a condition that may affect brain or sensory function or development; • History of a medical condition that may affect sleep and/or brain activity • History or presence of psychological/psychiatric conditions that may affect the subject's sleep and/or ability to follow experimental procedures; • Persons with substance abuse (alcohol or other substances) in the past 6 months • Nursing women or female subjects who are pregnant or planning to become pregnant. • Current or recent intake of medications with psychotropic effects (eg, antipsychotics, antidepressants, anxiolytics, psychostimulants, antihistamines, or beta-blockers - based on subject reporting and clinician judgment). • Insufficient sleep quality or irregular wake-sleep rhythm • Traveling to time zones with a time difference of more than 1 hour in the 2 weeks prior to the study days • Patients with extreme chronotypes (30 points or lower, or 70 points or higher on the Morningness-Eveningness questionnaire) • snoring
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) First part of the study: • EEG topographies and sources of modality-specific and supramodal responses • Differences in topographies at the scalp and source level and in trial-by-trial dynamics between evoked and spontaneous type I potentials 2) Second part of the study: • Correlation between the degree of sensory experience in the dream (visual, tactile, auditory) and the modality-specific component of the type I potential preceding the awakening (if present, result of first part of the study) • Correlation between the degree of surprise experienced in the dream and the supramodal component of type I potentials | — |
Secondary
| Measure | Time frame |
|---|---|
| • Differences in topographies at the scalp and source level and in trial-by-trial dynamics between type I potentials in sleep and wakefulness • Presence, latency and order of muscle activations recorded by EMG sensors in association with type I potentials • Presence and latency of pulse wave amplitude and heart beat variability changes associated with type I potentials | — |
Countries
Netherlands
Contacts
Netherlands Institute for Neuroscience